Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 1294 entries
View as:

A Study Using Flash Glucose Measurements for a New Once-weekly Insulin (Insulin Icodec) in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 9)

Phase: N/A Priority: Normal
NCT ID: NCT05823948 Org: User:
Start: 04/11/23 End: 04/11/24 Due: 04/11/25

Efficacy of Activated Recombinant Human Factor VII in Healthy Volunteers Treated for Punch Biopsy Mediated Bleeding

Phase: N/A Priority: Normal
NCT ID: NCT01561950 Org: User:
Start: 05/31/08 End: 01/31/09 Due: 01/31/10

A Regulatory Post-marketing Surveillance (rPMS) Study to Evaluate the Safety and Effectiveness of Saxenda®(Liraglutide 3.0 mg) in Obese Patients and Overweight Patients With Obesity-related Comorbidities in Routine Clinical Practice in Korea.

Phase: N/A Priority: Normal
NCT ID: NCT03560336 Org: User:
Start: 07/05/18 End: 12/02/20 Due: 12/02/21

A Regulatory Post Marketing Surveillance (rPMS) Study of Ryzodeg® FlexTouch® (Insulin Degludec /Insulin Aspart) to Evaluate Safety and Effectiveness in Patients With Diabetes Mellitus in Routine Clinical Practice in Korea

Phase: N/A Priority: Normal
NCT ID: NCT03416855 Org: User:
Start: 01/31/18 End: 05/19/20 Due: 05/19/21

A Trial Investigating the Efficacy and Safety of Flexible vs. Fixed Dosing and Simple vs. Stepwise Titration With Once Daily (OD) Insulin Degludec in Inadequately Treated Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01880736 Org: User:
Start: 06/30/13 End: 04/30/14 Due: 04/30/15

Safety, Tolerability, and Profile of Action of Drug in the Body of NN9535 in Healthy Male Japanese and Caucasian Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00851773 Org: User:
Start: 02/28/09 End: 10/31/09 Due: 10/31/10

A Research Trial Looking at the Comparability of 2 Different Concentrations of Semaglutide for the 0.5 Milligram (mg) Dose

Phase: N/A Priority: Normal
NCT ID: NCT05689099 Org: User:
Start: 01/17/23 End: 05/30/23 Due: 05/30/24

A First Human Dose Study Investigating Safety and Concentration of Study Medicine in the Blood Following Once Daily Oral Dosing of NNC0560-0004 in Healthy Adults.

Phase: N/A Priority: Normal
NCT ID: NCT06133270 Org: User:
Start: 11/13/23 End: 07/04/24 Due: 07/04/25

INITIATE Plus (INITiation of Insulin to Reach A1c TargEt) Study

Phase: N/A Priority: Normal
NCT ID: NCT00101751 Org: User:
Start: 10/31/04 End: 06/30/06 Due: 06/30/07

Safety of rFXIII in Patients Following First Time Myocardial Revascularization Requiring Cardiopulmonary Bypass

Phase: N/A Priority: Normal
NCT ID: NCT02239146 Org: User:
Start: 10/31/05 End: 01/31/08 Due: 01/31/09

Observational Study to Investigate the Occurrence of Bleeding in Postmenopausal Women Treated With Estradiol/NETA for 12 Months

Phase: N/A Priority: Normal
NCT ID: NCT01076621 Org: User:
Start: 05/31/10 End: 06/30/13 Due: 06/30/14

A Study Looking at How Insulin Icodec is Taken up in the Blood When Administered in Different Injection Sites in People With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT04582448 Org: User:
Start: 10/01/20 End: 09/27/21 Due: 09/27/22

Preference Study Between NovoFine® Autocover™ and a NovoFine® 8 mm Needle

Phase: N/A Priority: Normal
NCT ID: NCT01024218 Org: User:
Start: 12/01/04 End: 04/26/05 Due: 04/26/06

A Research Study of How a New Medicine Called Amycretin, Given as Tablets, Works in Japanese Men With Obesity

Phase: N/A Priority: Normal
NCT ID: NCT06049329 Org: User:
Start: 09/14/23 End: 12/15/23 Due: 12/15/24

Regulatory Post Marketing Surveillance (rPMS) Study of Rybelsus (Oral Semaglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea

Phase: N/A Priority: Normal
NCT ID: NCT05714683 Org: User:
Start: 03/31/25 End: 10/30/26 Due: 10/30/27

Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity in the Real World

Phase: N/A Priority: Normal
NCT ID: NCT06874751 Org: User:
Start: 12/06/24 End: 03/28/25 Due: 03/28/26

Somatropin Effect on Linear Growth and Final Height in Subjects With Noonan Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01529840 Org: User:
Start: 06/30/90 End: 09/30/05 Due: 09/30/06

Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT00097071 Org: User:
Start: 10/31/04 End: 05/31/06 Due: 05/31/07

Self-control Trial to Evaluate the Remission Rate in Newly Diagnosed Type 2 Diabetes Patients After Treatment With Insulin Aspart

Phase: N/A Priority: Normal
NCT ID: NCT00494988 Org: User:
Start: 12/31/04 End: 04/30/06 Due: 04/30/07

A Research Study Looking at How 50 mg Semaglutide Daily Affects Food Intake and Emptying of the Stomach in People With Obesity

Phase: N/A Priority: Normal
NCT ID: NCT05236517 Org: User:
Start: 02/08/22 End: 11/07/22 Due: 11/07/23

A Research Study to See How a New Weekly Insulin, Insulin Icodec When Given Along With Semaglutide Helps in Reducing the Blood Sugar Level in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT05813912 Org: User:
Start: 09/22/23 End: 07/25/25 Due: 07/25/26

Human Insulin NPH and Insulin Aspart in Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00597233 Org: User:
Start: 10/31/02 End: 12/31/02 Due: 12/31/03

A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIAsp in Subjects With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01924637 Org: User:
Start: 08/31/13 End: 11/30/13 Due: 11/30/14

Research Study Comparing a New Medicine Semaglutide to Liraglutide in People With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT03191396 Org: User:
Start: 06/27/17 End: 08/13/18 Due: 08/13/19

A Research Study Looking at How Safe it is to Switch From Emicizumab to Mim8 in People With Haemophilia A (FRONTIER 5)

Phase: N/A Priority: Normal
NCT ID: NCT05878938 Org: User:
Start: 06/26/23 End: 07/19/24 Due: 07/19/25